BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 12548214)

  • 21. Placenta growth factor is not an early marker for the development of severe preeclampsia.
    Livingston JC; Haddad B; Gorski LA; Neblett P; Ahokas RA; Ramsey R; Sibai BM
    Am J Obstet Gynecol; 2001 May; 184(6):1218-20. PubMed ID: 11349191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies.
    Holme AM; Roland MC; Henriksen T; Michelsen TM
    Am J Obstet Gynecol; 2016 Dec; 215(6):782.e1-782.e9. PubMed ID: 27503620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypoxia activates the human placental vascular endothelial growth factor system in vitro and in vivo: up-regulation of vascular endothelial growth factor in clinically relevant hypoxic ischemia in birth asphyxia.
    Trollmann R; Amann K; Schoof E; Beinder E; Wenzel D; Rascher W; Dötsch J
    Am J Obstet Gynecol; 2003 Feb; 188(2):517-23. PubMed ID: 12592265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.
    Maynard SE; Min JY; Merchan J; Lim KH; Li J; Mondal S; Libermann TA; Morgan JP; Sellke FW; Stillman IE; Epstein FH; Sukhatme VP; Karumanchi SA
    J Clin Invest; 2003 Mar; 111(5):649-58. PubMed ID: 12618519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of small-for-gestational-age neonates: screening by maternal biochemical markers at 30-34 weeks.
    Bakalis S; Gallo DM; Mendez O; Poon LC; Nicolaides KH
    Ultrasound Obstet Gynecol; 2015 Aug; 46(2):208-15. PubMed ID: 25826797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Placental vascularization in early onset small for gestational age and preeclampsia.
    van Oppenraaij RH; Bergen NE; Duvekot JJ; de Krijger RR; Hop Ir WC; Steegers EA; Exalto N
    Reprod Sci; 2011 Jun; 18(6):586-93. PubMed ID: 21321242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maternal plasma vascular endothelial growth factor concentrations in normal and hypertensive pregnancies and their relationship to peripheral vascular resistance.
    Bosio PM; Wheeler T; Anthony F; Conroy R; O'herlihy C; McKenna P
    Am J Obstet Gynecol; 2001 Jan; 184(2):146-52. PubMed ID: 11174494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Maternal serum concentration of placental growth factor (PIGF) and endothelial growth factor (VEGF) in pregnancies complicated by preeclampsia].
    Semczuk-Sikora A; Krzyzanowski A; Kwiatek M; Semczuk M
    Ginekol Pol; 2007 Nov; 78(11):873-6. PubMed ID: 18306920
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum levels of macrophage colony stimulating, vascular endothelial, and placenta growth factor in relation to later clinical onset of pre-eclampsia and a small-for-gestational age birth.
    Bersinger NA; Ødegård RA
    Am J Reprod Immunol; 2005 Aug; 54(2):77-83. PubMed ID: 16105099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risks for preeclampsia and small for gestational age: predictive values of placental growth factor, soluble fms-like tyrosine kinase-1, and inhibin A in singleton and multiple-gestation pregnancies.
    Boucoiran I; Thissier-Levy S; Wu Y; Wei SQ; Luo ZC; Delvin E; Fraser WD; Audibert F;
    Am J Perinatol; 2013 Aug; 30(7):607-12. PubMed ID: 23208763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Placental expression of vascular endothelial growth factor in placentae from pregnancies complicated by pre-eclampsia and intrauterine growth restriction does not support placental hypoxia at delivery.
    Lyall F; Young A; Boswell F; Kingdom JC; Greer IA
    Placenta; 1997 May; 18(4):269-76. PubMed ID: 9179920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of angiogenesis modulators in pregnant women with pre-eclampsia: a case-control study.
    Mundim GJ; Paschoini MC; Araujo Júnior E; Da Silva Costa F; Rodrigues Júnior V
    Arch Gynecol Obstet; 2016 Feb; 293(2):369-75. PubMed ID: 26205065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late-onset preeclampsia.
    Wikström AK; Larsson A; Eriksson UJ; Nash P; Nordén-Lindeberg S; Olovsson M
    Obstet Gynecol; 2007 Jun; 109(6):1368-74. PubMed ID: 17540809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating angiogenic factors in singleton vs multiple-gestation pregnancies.
    Maynard SE; Moore Simas TA; Solitro MJ; Rajan A; Crawford S; Soderland P; Meyer BA
    Am J Obstet Gynecol; 2008 Feb; 198(2):200.e1-7. PubMed ID: 18226624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated serum levels of vascular endothelial growth factor in patients with preeclampsia.
    Baker PN; Krasnow J; Roberts JM; Yeo KT
    Obstet Gynecol; 1995 Nov; 86(5):815-21. PubMed ID: 7566855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maternal serum placental growth factor (PlGF) isoforms 1 and 2 at 11-13 weeks' gestation in normal and pathological pregnancies.
    Nucci M; Poon LC; Demirdjian G; Darbouret B; Nicolaides KH
    Fetal Diagn Ther; 2014; 36(2):106-16. PubMed ID: 24457972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Placental growth hormone is increased in the maternal and fetal serum of patients with preeclampsia.
    Mittal P; Espinoza J; Hassan S; Kusanovic JP; Edwin SS; Nien JK; Gotsch F; Than NG; Erez O; Mazaki-Tovi S; Romero R
    J Matern Fetal Neonatal Med; 2007 Sep; 20(9):651-9. PubMed ID: 17701665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. First trimester screening of maternal placental protein 13 for predicting preeclampsia and small for gestational age: in-house study and systematic review.
    Schneuer FJ; Nassar N; Khambalia AZ; Tasevski V; Guilbert C; Ashton AW; Morris JM; Roberts CL
    Placenta; 2012 Sep; 33(9):735-40. PubMed ID: 22748852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concentrations of eNOS, VEGF, ACE and PlGF in maternal blood as predictors of impaired fetal growth in pregnancy complicated by gestational hypertension/preeclampsia.
    Wender-Ozegowska E; Zawiejska A; Iciek R; Brązert J
    Hypertens Pregnancy; 2015 Feb; 34(1):17-23. PubMed ID: 25181428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiogenic factors in maternal circulation and preeclampsia with or without fetal growth restriction.
    Vatten LJ; Åsvold BO; Eskild A
    Acta Obstet Gynecol Scand; 2012 Dec; 91(12):1388-94. PubMed ID: 22882089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.